Literature DB >> 27423695

Occludin S490 Phosphorylation Regulates Vascular Endothelial Growth Factor-Induced Retinal Neovascularization.

Xuwen Liu1, Alyssa Dreffs1, Monica Díaz-Coránguez1, E Aaron Runkle2, Thomas W Gardner1, Vince A Chiodo3, William W Hauswirth3, David A Antonetti4.   

Abstract

Occludin is a transmembrane tight junction protein that contributes to diverse cellular functions, including control of barrier properties, cell migration, and proliferation. Vascular endothelial growth factor (VEGF) induces phosphorylation of occludin at S490, which is required for VEGF-induced endothelial permeability. Herein, we demonstrate that occludin S490 phosphorylation also regulates VEGF-induced retinal endothelial cell proliferation and neovascularization. Using a specific antibody, phospho-occludin was located in centrosomes in endothelial cell cultures, animal models, and human surgical samples of retinal neovessels. Occludin S490 phosphorylation was found to increase with endothelial tube formation in vitro and in vivo during retinal neovascularization after induction of VEGF expression. More important, expression of occludin mutated at S490 to Ala, completely inhibited angiogenesis in cell culture models and in vivo. Collectively, these data suggest a novel role for occludin in regulation of endothelial proliferation and angiogenesis in a phosphorylation-dependent manner. These findings may lead to methods of regulating pathological neovascularization by specifically targeting endothelial cell proliferation.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27423695      PMCID: PMC5012506          DOI: 10.1016/j.ajpath.2016.04.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Platelet-derived growth factor mediates tight junction redistribution and increases permeability in MDCK cells.

Authors:  Nicole S Harhaj; Alistair J Barber; David A Antonetti
Journal:  J Cell Physiol       Date:  2002-12       Impact factor: 6.384

2.  XIAP therapy increases survival of transplanted rod precursors in a degenerating host retina.

Authors:  Jingyu Yao; Kecia L Feathers; Hemant Khanna; Debra Thompson; Catherine Tsilfidis; William W Hauswirth; John R Heckenlively; Anand Swaroop; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

Review 3.  The centrosome in cells and organisms.

Authors:  Michel Bornens
Journal:  Science       Date:  2012-01-27       Impact factor: 47.728

Review 4.  Diabetic retinopathy.

Authors:  David A Antonetti; Ronald Klein; Thomas W Gardner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

5.  Epithelial transport and barrier function in occludin-deficient mice.

Authors:  J D Schulzke; A H Gitter; J Mankertz; S Spiegel; U Seidler; S Amasheh; M Saitou; S Tsukita; M Fromm
Journal:  Biochim Biophys Acta       Date:  2005-05-15

Review 6.  Tight junction proteins: from barrier to tumorigenesis.

Authors:  E Aaron Runkle; David Mu
Journal:  Cancer Lett       Date:  2013-06-03       Impact factor: 8.679

7.  Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells.

Authors:  Tatsuya Katsuno; Kazuaki Umeda; Takeshi Matsui; Masaki Hata; Atsushi Tamura; Masahiko Itoh; Kosei Takeuchi; Toshihiko Fujimori; Yo-ichi Nabeshima; Tetsuo Noda; Shoichiro Tsukita; Sachiko Tsukita
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

8.  Par6γ is at the mother centriole and controls centrosomal protein composition through a Par6α-dependent pathway.

Authors:  Valérian Dormoy; Kati Tormanen; Christine Sütterlin
Journal:  J Cell Sci       Date:  2012-12-21       Impact factor: 5.285

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Caspase inhibition with XIAP as an adjunct to AAV vector gene-replacement therapy: improving efficacy and prolonging the treatment window.

Authors:  Jingyu Yao; Lin Jia; Naheed Khan; Qiong-Duan Zheng; Ashley Moncrief; William W Hauswirth; Debra A Thompson; David N Zacks
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

View more
  17 in total

Review 1.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

Review 2.  Phosphorylation of tight junction transmembrane proteins: Many sites, much to do.

Authors:  Christina M Van Itallie; James M Anderson
Journal:  Tissue Barriers       Date:  2017-10-30

Review 3.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

4.  WNK1 collaborates with TGF-β in endothelial cell junction turnover and angiogenesis.

Authors:  Ankita B Jaykumar; Sakina Plumber; David M Barry; Derk Binns; Chonlarat Wichaidit; Magdalena Grzemska; Svetlana Earnest; Elizabeth J Goldsmith; Ondine Cleaver; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

5.  Serine 408 phosphorylation is a molecular switch that regulates structure and function of the occludin α-helical bundle.

Authors:  Atul K Srivastava; Bharat Somireddy Venkata; Yan Y Sweat; Heather R Rizzo; Léa Jean-François; Li Zuo; Kathleen W Kurgan; Patrick Moore; Nitesh Shashikanth; Izabela Smok; Joseph R Sachleben; Jerrold R Turner; Stephen C Meredith
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

Review 6.  WNK1 in Malignant Behaviors: A Potential Target for Cancer?

Authors:  Ji-Ung Jung; Ankita B Jaykumar; Melanie H Cobb
Journal:  Front Cell Dev Biol       Date:  2022-06-22

7.  Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer.

Authors:  Xue-Qi Liu; Xin-Rong Shao; Ye Liu; Zhao-Xia Dong; Sze-Hoi Chan; Yuan-Yuan Shi; Shu-Na Chen; Lin Qi; Li Zhong; Yue Yu; Ting Lv; Peng-Fei Yang; Li-Yan Li; Xiao-Bin Wang; Xu-Dong Zhang; Xin Li; Wenxue Zhao; Lalit Sehgal; Miao Li; Xing-Ding Zhang
Journal:  Oncogene       Date:  2021-11-15       Impact factor: 8.756

8.  Atypical Protein Kinase C: Breaking Down Barriers in Ocular Disease?

Authors:  Elizabeth A Pearsall; Kip M Connor
Journal:  Am J Pathol       Date:  2018-09-13       Impact factor: 4.307

Review 9.  Organ-On-A-Chip Technologies for Advanced Blood-Retinal Barrier Models.

Authors:  Héloïse Ragelle; Andreia Goncalves; Stefan Kustermann; David A Antonetti; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2019-05-29       Impact factor: 2.671

10.  Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes.

Authors:  Andreia Goncalves; Alyssa Dreffs; Cheng-Mao Lin; Sarah Sheskey; Natalie Hudson; Jason Keil; Matthew Campbell; David A Antonetti
Journal:  Diabetes       Date:  2021-04-21       Impact factor: 9.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.